Dermatology Laser Vein Specialists of the Carolinas (DLVSC) is hosting a learning event and open house with free consultations and a live demo of the all new Kybellaâ„¢ double chin reduction treatment.

DLVSC was the only Charlotte practice to participate in the Kybellaâ„¢ FDA trial, making Dr. Gilly Munavalli one of the most experienced Kybellaâ„¢ injectors in the nation.

DLSVC Patient Before & After Kybella Treatment

DLSVC Patient Before & After Kybella Treatment

The event will be Tuesday, July 28th from 5pm-7pm, and you’ll enjoy light appetizers and drinks along with complimentary consultations and a live demonstration of the Kybellaâ„¢ treatment.  This double chin reduction treatment is definitely for both men & women, so it would work for either or both of you to attend.

Dr. Munavalli will be holding a “what’s next for the neck” seminar (at 6 pm) about new and alternate treatment options to improve the appearance of your neck. Then Dr. Munavalli will perform a live Kybella™ demo around 6:30 pm, so you can see how the treatment goes.

In addition, one of the first patients to receive the treatment from DLVSC – who was featured on Good Morning America  – will be attending to answer your questions about how it worked for her.

The Kybella™ Open House will be held on Tuesday, July 28th from 5-7 pm at DLVSC’s Charlotte location: 1918 Randolph Road, Suite 550, Charlotte NC 28207

Appointments are encouraged so please rsvp now to 704-375-6766 to schedule yours.

kybella at DLVSC

Dr. Gilly S. Munavalli is a nationally renowned dermatologist, researcher and clinical investigator for medical and cosmetic dermatology. With fellowships and internships from institutions including Johns Hopkins University, the University of California, San Francisco, and the Mayo Clinic, Dr. Munavalli is experienced in cosmetic treatments and technologies, Mohs surgery, advanced laser surgery and vein surgery. The practice houses one of the most extensive collection of lasers, light sources and innovative cosmetic and medical treatments in the U.S. and includes a vibrant clinical research group that partakes in cutting-edge research and technology for dermatologic surgery.